25-Jul-2022 | Facts and Factors
According to Facts and Factors, the global morphine sulfate market size was valued at USD 2.3 billion in 2021 and is predicted to increase at a CAGR of 7.9% to USD 6.5 billion by 2028. The study examines the market in terms of revenue in each of the major regions, which are classified into countries.
The rising prevalence of chronic pain-related disorders on a global scale has increased demand for pain management drugs and treatments and will majorly influence the Morphine sulfate market potential in the years to come. The increasing focus on healthcare will drive the Morphine sulfate market potential in multiple regions across the world. Morphine reduces pain by binding with opioid receptors that are present in the central nervous system of the patient. This is used to reduce pain in chronic diseases and help them make it bearable for suitable treatment opportunities.
Browse the full “ Morphine Sulfate Market By Product Types (Superior Grade, General Grade), By Application (Oral Tablets, Injection, Capsule, Others), and By Region - Global Industry Insights, Growth, Size, Share, Comparative Analysis, Trends, Statistical Research, Market Intelligence, and Forecast 2022 – 2028" report at https://www.fnfresearch.com/morphine-sulfate-market
The increasing geriatric population, rising prevalence of chronic diseases, increasing healthcare spending, rising focus on pain management, and increasing consumption of Morphine sulfate are major factors that drive the Morphine sulfate market growth over the forecast period. However, dependency and risk of substance abuse by Morphine sulfate are major factors that will hinder the Morphine sulfate market growth on a global scale.
In terms of application, the morphine sulfate market is further segmented into Oral Tablets, Injections, Capsule, and Others. Of these, the oral tablets segment is expected to have a dominant outlook and will see good growth in the coming years through 2028. The rising use of Morphine sulfate injections in order to provide faster relief will drive the demand in the injection segment as well. Increasing consumption of Morphine sulfate is expected to be driven by high demand for pain management but will be hampered by the risk of substance abuse and addiction.
The North American morphine sulfate market is expected to lead the global morphine sulfate industry and is anticipated to account for a major market share over the forecast period owing to the presence of developed healthcare infrastructure. The rising consumption of Morphine sulfate is expected to be driven by a rising aging population and increasing instances of chronic pain in multiple disorders and diseases. The United States and Canada are projected to be the notable markets in this region owing to the rising focus on pain management in the medical industry. High demand for Morphine sulfate is expected to be seen in the Asia Pacific region owing to the rising focus on healthcare in this region. China and India are predicted to be lucrative markets for Morphine sulfate over the coming years.
Report Scope
Report Attribute |
Details |
Market Size in 2021 |
USD 2.3 Billion |
Projected Market Size in 2028 |
USD 6.5 Billion |
CAGR Growth Rate |
7.9% CAGR |
Base Year |
2021 |
Forecast Years |
2022-2028 |
Key Market Players |
Mallinckrodt Pharmaceuticals, Alcaliber, Purdue Pharma, Cepia-Sanofi, Macfarlan Smith, SUN PHARMA, Qinghai Pharmaceutical, Taj Pharmaceuticals, Northeast Pharm, and Others |
Key Segment |
By Product Types, Application, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
The report contains qualitative and quantitative research on the global Morphine sulfate Market, as well as detailed insights and development strategies employed by the leading competitors. The report also provides an in-depth analysis of the market's main competitors, as well as information on their competitiveness. The research also identifies and analyses important business strategies used by these main market players, such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts. The study examines, among other things, each company's global presence, competitors, service offers, and standards.
Some of the major companies operating in the global morphine sulfate market are Mallinckrodt Pharmaceuticals, Alcaliber, Purdue Pharma, Cepia-Sanofi, Macfarlan Smith, SUN PHARMA, Qinghai Pharmaceutical, Taj Pharmaceuticals, Northeast Pharm, and others.
The Global Corporate Morphine Sulfate is segmented as follows:
By Product types
- Superior grade
- General grade
By Application
- Oral Tablets
- Injection
- Capsule
- Others
By Region
- North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com
